Breaking News

Dishman’s Netherlands Site Completes FDA Inspection

Found to be compliant with cGMP principles and guidelines

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dishman Group has successfully completed an inspection by the U.S. FDA for its Netherlands site, confirming the site is compliant with cGMP principles and guidelines. Dishman Netherlands, located in Veenendaal, sells and manufactures Vitamin D analogues, Vitamin D, Cholesterol and lanolin related products for pharmaceutical, cosmetic, food, feed and industry applications, and is equipped with a full cGMP production lab. “This success is the result of great team work. I would like to express my ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters